News Focus
News Focus
icon url

BIOChecker4

08/31/24 4:06 PM

#468692 RE: falconer66a #468690

Totally ridiculous. I think it’s safe to say everyone here would like to see Anavex be successful, for the benefit of shareholders as well as patients. My frustration is that while the science appears to have some merit, we have an incompetent CEO who can’t get the job done.
icon url

frrol

08/31/24 4:11 PM

#468693 RE: falconer66a #468690

They don't know, nor do you. No need for dramatics, take a moment.
The paper is now conspicuously overdue. Hopefully it's not an indication of difficulties with any journal. The PD and FX trial starts are also taking far longer than expected, which is disappointing. Let's see what Sept brings. I'm pretty confident the AD MAA package can be delivered in early Q4, as Missling has recently projected.
icon url

tredenwater2

09/01/24 11:44 AM

#468726 RE: falconer66a #468690

Absolutely right!

and that there was some sort of skullduggery involved in the drug's approval.



Unless Dr. Missling gets 10 out of the 12 advisory members (after one resigns in protest) to vote against the approval of Blarcasamine for Alzheimer’s then we dont stand a chance!

Maybe thats what is actually taking so long, its a slow walk into “protestant” approval! 🤣

Keep up the good work calling them out Falconer.
icon url

kund

09/01/24 11:59 AM

#468727 RE: falconer66a #468690

Should Anavex ever get one of its drugs approved for sale and use anywhere in the world,



Why is there doubt about drug approval? Something changed after such long delay and 30% dropout from tiny trial?